Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 562, pseudogene (RNU6-562P) is a human RNA gene classified as a pseudogene, specifically a member of the U6 small nuclear RNA (snRNA) pseudogene family[1][5]. U6 snRNA pseudogenes arise from the highly expressed and essential U6 snRNA gene, which itself is a critical component of the spliceosome in pre-mRNA splicing. However, as a pseudogene, RNU6-562P does not code for a functional RNA molecule and lacks biological activity[1][2][6]. Pseudogenes like RNU6-562P are typically regarded as non-functional genomic elements generated by gene duplication or retrotransposition events, and are not transcribed into functional RNA or protein products in healthy tissues[2][6]. There is no evidence that this pseudogene plays a role as a therapeutic target, nor are there disease associations, biomarkers, or known drug interactions related to this locus[1][4][5]. Note: This entry is not a functional target and is generally omitted from therapeutic or biomarker analyses. Its inclusion may be due to automated or overbroad pseudogene annotation pipelines[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 562, pseudogene (RNU6-562P).